Prospera Financial Services Inc Cara Therapeutics, Inc. Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$7.45 - $13.84 $1,862 - $3,460
-250 Reduced 20.16%
990 $9,000
Q1 2022

May 04, 2022
BUY
$9.94 - $12.65 $12,325 - $15,686
1,240 New
1,240 $15,000
Q4 2020

Feb 12, 2021
SELL
$12.72 - $16.16 $23,124 - $29,378
-1,818 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$12.34 - $17.92 $22,434 - $32,578
1,818 New
1,818 $23,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email